Intellectual Property Rights During—and After—a Pandemic
Much-needed medical supplies were developed and manufactured quickly during the rapid response to the COVID-19 pandemic. Medical device manufacturers as well as new players stepped up to fill urgent demands. But how did intellectual property fare in the global manufacturing flurry?
Sharon Hwang, shareholder and executive committee member at McAndrews, Held & Malloy, answers MD+DI’s questions on the unprecedented pandemic manufacturing and on any impacts to IP rights. Hwang is a patent and technology attorney focused on helping innovative companies protect, monetize, and enforce their intellectual property.
Source: Medical Device and Diagnostic Industry